AUPH
Aurinia Pharmaceuticals Inc.
Nasdaq Pharmaceutical Preparations Large accelerated filer

Key Financials

Revenue
$283.1M
↑ 267.1%
Operating Income
$104.9M
↑ 215.6%
Net Income
$287.2M
↑ 36.2%
EPS (Diluted)
$2.07
↑ 35.3%
Total Assets
$751.6M
↑ 36.5%
Total Liabilities
$170.3M
↓ 1.7%
Cash & Equivalents
$80.2M
↓ 3.9%
Shareholders' Equity
$581.3M
↑ 54.0%

Recent SEC Filings

Form Type Filed Date Link
4 6/8/2026 View on SEC
4 6/8/2026 View on SEC
4 6/8/2026 View on SEC
4 6/8/2026 View on SEC
144 6/5/2026 View on SEC
SCHEDULE 13D/A 6/4/2026 View on SEC
8-K 6/4/2026 View on SEC
144 6/4/2026 View on SEC
4 6/2/2026 View on SEC
144 6/2/2026 View on SEC

Company Information

Field Value
Ticker AUPH
Company Name Aurinia Pharmaceuticals Inc.
CIK 1600620
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
Phone 250-744-2487